Jiankang Hu

机构：Jiangxi Pingxiang People's Hospital

发表论文 37 篇 · 总被引 492 次 · h-index 9

代表论文

• Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial (2023 · Annals of the Rheumatic Diseases · 被引 146)
• A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus (2025 · New England Journal of Medicine · 被引 36)
• Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis (2025 · JAMA Network Open · 被引 14)
• Firsekibart in acute gouty arthritis (2025 · Journal of Translational Medicine · 被引 12)
• Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study (2023 · The Lancet Regional Health - Western Pacific · 被引 10)
• Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial (2025 · The Innovation · 被引 8)